October 30, 2026

Phibro Animal Health Corporatio (PAHC)

⚠️ No article content returned.

..

MeiraGTx Holdings plc (MGTX): Analyzing the 185.94% Potential Upside for Investors

MeiraGTx Holdings plc (NASDAQ: MGTX) presents an intriguing opportunity for investors, especially those with an appetite for high-risk, high-reward biotechnology plays. With an impressive market capitalization..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 52% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS) has recently caught the attention of investors with its compelling potential upside of 52.35%, according to analyst target prices. As a..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Promising 23.62% Upside for Biotech Investors

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is capturing the attention of investors with its bold strides in the biotechnology sector. With a market capitalization of $9.25 billion,..

Immatics N.V. (IMTX) Stock Analysis: Unveiling a 132% Upside Potential Amidst Robust Revenue Growth

Immatics N.V. (NASDAQ: IMTX) is making waves in the biotechnology sector with its pioneering research in T cell redirecting immunotherapies for cancer treatment. Headquartered in Tübingen,..

Talkspace, Inc. (TALK) Stock Analysis: Understanding the 21.43% Upside Potential

Talkspace, Inc. (NASDAQ: TALK), a prominent player in the virtual behavioral healthcare sector, offers a unique investment opportunity with a potential upside of 21.43% based on..

Cronos Group Inc. (CRON) Stock Analysis: Navigating Revenue Growth Amidst Valuation Challenges

Cronos Group Inc. (CRON), a notable player in the global cannabis market, is currently making waves with its impressive revenue growth figures. As an investor, understanding..

Cel-Sci Corporation (CVM) Investor Outlook: Exploring a Potential 733% Upside in the Biotechnology Sector

Cel-Sci Corporation (NASDAQ: CVM), a U.S.-based biotechnology firm, has been making waves in the healthcare sector with its pioneering research and development efforts focused on harnessing..

Bioventus Inc. (BVS)

⚠️ No article content returned.

..

Prothena Corporation (PRTA) Stock Analysis: Exploring a 140% Upside Potential Amidst Clinical Innovations

Investors with an eye on the biotechnology sector might find Prothena Corporation plc (NASDAQ: PRTA) an intriguing prospect, especially given its considerable upside potential. This Ireland-based..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 69.64% Upside Potential

Definitive Healthcare Corp. (NASDAQ: DH), a leader in the health information services industry, presents a fascinating case for investors seeking opportunities in the healthcare sector. Headquartered..

Dianthus Therapeutics (DNTH): Analyst Consensus Predicts 68% Upside Potential for Biotech Innovator

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a dynamic player in the biotechnology sector, has caught the attention of investors with its ambitious pipeline targeting severe autoimmune diseases...

Zymeworks Inc. (ZYME) Investor Outlook: A 44.55% Potential Upside Amidst Biotech Volatility

Zymeworks Inc. (NASDAQ: ZYME), a promising player in the biotechnology sector, is currently capturing investor attention with a significant potential upside of 44.55%. Trading at $28.71,..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech Contender with 473% Potential Upside

For investors with an appetite for high-risk, high-reward opportunities, LENZ Therapeutics, Inc. (NASDAQ: LENZ) is a biotechnology company that warrants attention. Based in Solana Beach, California,..

uniQure N.V. (QURE) Stock Analysis: Exploring a 138.60% Potential Upside in the Biotech Arena

uniQure N.V. (NASDAQ: QURE), a pioneering force in the biotechnology sector, is making waves with its ambitious gene therapy treatments targeting rare and severe diseases. With..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking a Potential 218% Upside in the Biotech Sector

REGENXBIO Inc. (NASDAQ: RGNX), a pioneering biotechnology company based in Rockville, Maryland, is making waves with its innovative approach to gene therapy. The company’s focus on..

Ginkgo Bioworks Holdings (DNA) Investor Outlook: Challenges and Opportunities Amidst Market Volatility

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) continues to be a fascinating player in the biotechnology sector, offering innovative solutions in cell engineering and biosecurity. Despite its..

Neuropace, Inc. (NPCE) Stock Analysis: A 53.73% Potential Upside in the Medical Device Sector

Investors looking to tap into the burgeoning medical device sector might find Neuropace, Inc. (NASDAQ: NPCE) a compelling option. This Mountain View, California-based company is setting..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Is a 144% Upside Within Reach?

Investors seeking unique opportunities in the healthcare sector might consider taking a closer look at Organogenesis Holdings Inc. (NASDAQ: ORGO). Despite the current challenges, the company..

CeriBell, Inc. (CBLL) Stock Analysis: Riding High on Strong Revenue Growth and Bullish Analyst Ratings

CeriBell, Inc. (NASDAQ: CBLL), a healthcare pioneer in the medical devices sector, has been capturing the attention of investors with its innovative approach to EEG technology...

Search

Funds

October 30, 2026

Search

Funds

October 30, 2026

FTSE 100

Funds